James Huang, Director at WINDTREE THERAPEUTICS INC /DE/ (WINT), bought 50,000 shares at $1.90 ($95K) on 2021-10-19, disclosed to the SEC on 2021-10-19.
Open-market purchase of $95k WINT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| ATRA | SELL | 2026-01-14 | $489K | — | Filing → |
| ATRA | BUY | 2025-07-21 | $373K | — | Filing → |
| CASI | BUY | 2022-09-08 | $304K | — | Filing → |